Chatham Capital Group’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-27,260
| Closed | -$2.53M | – | 192 |
|
|
2021
Q1 | $2.53M | Buy |
27,260
+1,225
| +5% | +$114K | 0.53% | 62 |
|
|
2020
Q4 | $2.33M | Buy |
26,035
+27
| +0.1% | +$2.42K | 0.52% | 57 |
|
|
2020
Q3 | $2.69M | Sell |
26,008
-269
| -1% | -$27.8K | 0.66% | 44 |
|
|
2020
Q2 | $2.08M | Buy |
26,277
+134
| +0.5% | +$10.6K | 0.54% | 52 |
|
|
2020
Q1 | $1.51M | Sell |
26,143
-477
| -2% | -$27.6K | 0.45% | 54 |
|
|
2019
Q4 | $1.44M | Buy |
26,620
+48
| +0.2% | +$2.59K | 0.35% | 80 |
|
|
2019
Q3 | $1.39M | Sell |
26,572
-130
| -0.5% | -$6.8K | 0.35% | 74 |
|
|
2019
Q2 | $1.29M | Sell |
26,702
-110
| -0.4% | -$5.31K | 0.32% | 85 |
|
|
2019
Q1 | $1.36M | Buy |
26,812
+5,789
| +28% | +$293K | 0.35% | 80 |
|
|
2018
Q4 | $1.25M | Buy |
21,023
+2,118
| +11% | +$126K | 0.35% | 74 |
|
|
2018
Q3 | $1.25M | Hold |
18,905
| – | – | 0.31% | 77 |
|
|
2018
Q2 | $955K | Buy |
18,905
+425
| +2% | +$21.5K | 0.25% | 86 |
|
|
2018
Q1 | $973K | Sell |
18,480
-600
| -3% | -$31.6K | 0.26% | 82 |
|
|
2017
Q4 | $887K | Buy |
19,080
+180
| +1% | +$8.37K | 0.24% | 82 |
|
|
2017
Q3 | $765K | Hold |
18,900
| – | – | 0.22% | 93 |
|
|
2017
Q2 | $641K | Buy |
+18,900
| New | +$641K | 0.18% | 102 |
|